Area of research
Genetics · Epidemiology
Research interest
Research interests include Inflammatory Bowel Disease, Microscopic Colitis, Rheumatoid Arthritis Research and Therapies, and Eosinophilic Esophagitis.
Comparative Safety of Janus Kinase Inhibitors vs Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases
AGA Living Clinical Practice Guideline on the Pharmacologic Management of Moderate-to-Severe Crohn’s Disease
AGA Living Clinical Practice Guideline on Pharmacological Management of Moderate-to-Severe Ulcerative Colitis
Global Prevalence of Advanced Liver Fibrosis and Cirrhosis in the General Population: A Systematic Review and Meta-analysis
Red Flag Signs and Symptoms for Patients With Early-Onset Colorectal Cancer
Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Ulcerative Colitis: 2024 American Gastroenterological Association Evidence Synthesis
Modern Advanced Therapies for Inflammatory Bowel Diseases: Practical Considerations and Positioning
Comparative Efficacy of Biologics and Small Molecule in Ulcerative Colitis: A Systematic Review and Network Meta-analysis
Comparative Efficacy of Advanced Therapies for Achieving Endoscopic Outcomes in Crohn’s Disease: A Systematic Review and Network Meta-Analysis
Health care–related transportation insecurity is associated with adverse health outcomes among adults with chronic liver disease
Epidemiology of Elderly Onset IBD: A Nationwide Population-Based Cohort Study
Management of complications in patients with an ileostomy: an umbrella review of systematic reviews for the EndOTrial Consortium
Patterns in Cancer Incidence Among People Younger Than 50 Years in the US, 2010 to 2019
AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Ulcerative Colitis
AGA Clinical Practice Guideline on the Management of Pouchitis and Inflammatory Pouch Disorders
AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Crohn’s Disease
Management of inflammatory bowel diseases in older adults
Risk of Major Adverse Cardiovascular Events in Immune-Mediated Inflammatory Disorders on Biologics and Small Molecules: Network Meta-Analysis
Efficacy and Safety of Advanced Oral Small Molecules for Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
Prevalence of Barrett’s Esophagus and Esophageal Adenocarcinoma With and Without Gastroesophageal Reflux: A Systematic Review and Meta-analysis
Dynamics of the Gut Mycobiome in Patients With Ulcerative Colitis
HLA-DQA1∗05 Genotype and Immunogenicity to Tumor Necrosis Factor-α Antagonists: A Systematic Review and Meta-analysis
Pharmacological Therapies for the Management of Fistulizing Crohn’s Disease: A Systematic Review and Meta-Analysis
Comparative Speed of Early Symptomatic Remission With Advanced Therapies for Moderate-to-Severe Ulcerative Colitis: A Systematic Review and Network Meta-Analysis
Efficacy and Safety of IL-12/23 and IL-23 Inhibitors for Crohn’s Disease: Systematic Review and Meta-Analysis
Integrating Evidence to Guide Use of Biologics and Small Molecules for Inflammatory Bowel Diseases
Scoring Indices for Perianal Fistulising Crohn’s Disease: A Systematic Review
Withdrawal of Immunomodulators or TNF Antagonists in Patients With Inflammatory Bowel Diseases in Remission on Combination Therapy: A Systematic Review and Meta-analysis
Comparative Safety of Biologic Agents in Patients With Inflammatory Bowel Disease With Active or Recent Malignancy: A Multi-Center Cohort Study
Frailty and Risk of Serious Infections in Patients With Rheumatoid Arthritis Treated With Biologic or <scp>Targeted‐Synthetic Disease‐Modifying</scp> Antirheumatic Drugs